Sanctuary Advisors LLC Sells 16,918 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Sanctuary Advisors LLC cut its stake in shares of Phibro Animal Health Co. (NASDAQ:PAHC) by 59.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 11,747 shares of the company’s stock after selling 16,918 shares during the quarter. Sanctuary Advisors LLC’s holdings in Phibro Animal Health were worth $279,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Brandes Investment Partners LP increased its holdings in Phibro Animal Health by 1.2% in the 2nd quarter. Brandes Investment Partners LP now owns 2,405,629 shares of the company’s stock worth $40,521,000 after purchasing an additional 29,071 shares in the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Phibro Animal Health by 5.7% in the second quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company’s stock valued at $13,005,000 after buying an additional 42,086 shares during the period. Acadian Asset Management LLC raised its holdings in Phibro Animal Health by 6.3% in the 2nd quarter. Acadian Asset Management LLC now owns 717,506 shares of the company’s stock valued at $12,027,000 after buying an additional 42,299 shares during the last quarter. Dana Investment Advisors Inc. boosted its position in Phibro Animal Health by 17.2% during the 2nd quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company’s stock worth $8,619,000 after buying an additional 75,546 shares during the period. Finally, Geode Capital Management LLC grew its holdings in Phibro Animal Health by 5.7% during the 3rd quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock worth $11,430,000 after acquiring an additional 27,201 shares during the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on PAHC. Morgan Stanley lifted their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the stock an “equal weight” rating in a report on Tuesday, December 17th. StockNews.com downgraded Phibro Animal Health from a “strong-buy” rating to a “buy” rating in a report on Friday. Barclays increased their price target on Phibro Animal Health from $13.00 to $20.00 and gave the company an “underweight” rating in a research note on Tuesday, November 12th. Finally, JPMorgan Chase & Co. started coverage on Phibro Animal Health in a research note on Tuesday, September 10th. They issued a “neutral” rating and a $22.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and one has given a buy rating to the company’s stock. According to data from MarketBeat, Phibro Animal Health has a consensus rating of “Hold” and a consensus target price of $20.50.

Phibro Animal Health Price Performance

PAHC stock opened at $21.05 on Friday. The company has a quick ratio of 1.69, a current ratio of 3.23 and a debt-to-equity ratio of 1.81. The company’s fifty day simple moving average is $23.29 and its 200 day simple moving average is $20.87. Phibro Animal Health Co. has a 12-month low of $10.03 and a 12-month high of $25.98. The firm has a market cap of $852.59 million, a price-to-earnings ratio of 48.95, a PEG ratio of 0.58 and a beta of 0.51.

Phibro Animal Health Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Wednesday, December 18th. Investors of record on Wednesday, November 27th were given a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, November 27th. This represents a $0.48 annualized dividend and a dividend yield of 2.28%. Phibro Animal Health’s payout ratio is 111.63%.

Phibro Animal Health Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.